|
KRTCAP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.13389999611968E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.54889999995456E-07 |
| Normal-vs-Stage2 |
1.212070E-02 |
| Normal-vs-Stage3 |
6.50499999976795E-07 |
| Normal-vs-Stage4 |
5.32850000012353E-07 |
| Stage1-vs-Stage2 |
8.697800E-01 |
| Stage1-vs-Stage3 |
3.822600E-01 |
| Stage1-vs-Stage4 |
2.471800E-01 |
| Stage2-vs-Stage3 |
5.299600E-01 |
| Stage2-vs-Stage4 |
3.547600E-01 |
| Stage3-vs-Stage4 |
6.683200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.91829999662829E-08 |
| Normal-vs-AfricanAmerican |
1.962070E-03 |
| Normal-vs-Asian |
2.358900E-04 |
| Caucasian-vs-AfricanAmerican |
6.716400E-01 |
| Caucasian-vs-Asian |
4.949600E-01 |
| AfricanAmerican-vs-Asian |
4.124800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.97489999698553E-08 |
| Normal-vs-Female |
1.39189999970313E-07 |
| Male-vs-Female |
1.254550E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.47850000001382E-06 |
| Normal-vs-Age(41-60Yrs) |
1.14690000052597E-07 |
| Normal-vs-Age(61-80Yrs) |
3.98980000000382E-05 |
| Normal-vs-Age(81-100Yrs) |
7.827600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.761000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.534800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.142200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.406200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.134800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.674200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.098400E-01 |
| Classical-VS-Follicular |
8.425200E-01 |
| Classical-VS-Other |
8.544000E-01 |
| Classical-VS-Normal |
4.94709999632192E-08 |
| Tall-VS-Follicular |
8.085000E-01 |
| Tall-VS-Other |
8.320800E-01 |
| Tall-VS-Normal |
6.009300E-04 |
| Follicular-VS-Other |
8.688600E-01 |
| Follicular-VS-Normal |
1.351710E-04 |
| Other-VS-Normal |
2.499600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.37300000444685E-08 |
| Normal-vs-N1 |
1.81105000000015E-05 |
| N0-vs-N1 |
7.684400E-02 |
|
|
